Safety and Pharmacokinetics Study in VLBW Neonates With BSYX-A110

Clinical trial NCT00631878 · COMPLETED

Trial details

NCT number: NCT00631878
Sponsor: Biosynexus Incorporated
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neonatal Staphylococcal Sepsis

Start date: 2001-11-01
Primary completion: 2003-05-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.